The severe allergic reaction of a sanitary in Alaska to Pfizer's COVID-19 vaccine
The woman had an anaphylactic response that began 10 minutes after receiving the drug at Bartlett Regional Hospital in Juneau.
Last Monday, the United States began the vaccination campaign with the remedy developed by Pfizer. As The New York Times revealed, on Tuesday, an Alaskan sanitary had a severe allergic reaction after receiving it and remained hospitalized Wednesday morning for observation.
The middle-aged woman had no history of allergies but had an anaphylactic reaction that began 10 minutes after receiving the vaccine at Bartlett Regional Hospital in Juneau, Alaska. This response was accompanied by flushing and respiratory distress. Lindy Jones, director of the hospital's emergency department, said that the reaction diminished when the hospital was treated with epinephrine. Likewise, he assured in the newspaper that "she is healthy and well."
Similar to UK reactions
According to The New York Times, government officials are gathering more information regarding the case. The Alaskan worker's reaction was similar to that suffered by two toilets in Britain after receiving the same vaccine last week, although both recovered. This Thursday, scientists from the US Food and Drug Administration (FDA) meet to evaluate the vaccine developed by Moderna, which uses the same type of technology as Pfizer's and is based on messenger RNA.
No serious effects
When Pfizer conducted its trial with more than 40,000 participants, no serious adverse effects were detected beyond pain or fever. Jerica Pitts, one of Pfizer's spokespersons, stressed that the company does not yet have all the details of the case but works with local authorities. "We will closely monitor all reports suggesting serious allergic reactions after vaccination and update the label language if necessary," said Pitts.